文献速递心境障碍精神分裂症与精神病性障碍焦虑、强迫与应激相关障碍

精神障碍患者肠道菌群组成扰动:综述与荟萃分析

Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该综述与荟萃分析纳入59项病例对照研究,评估成人精神障碍患者肠道菌群改变,并对34项研究(1519例患者、1429例对照)进行α多样性荟萃分析。患者微生物丰富度显著降低,但仅在双相障碍中一致;β多样性差异仅见于重性抑郁障碍和精神分裂症;跨诊断模式为抗炎产丁酸菌减少、促炎菌富集。

要点

  • 患者微生物丰富度显著降低,但仅双相障碍一致。
  • β多样性差异仅见于重性抑郁障碍和精神分裂症。
  • 跨诊断模式:产丁酸菌减少、促炎菌富集。

核心结论

  • 精神障碍患者肠道菌群扰动呈跨诊断模式,表现为某些抗炎产丁酸菌减少和促炎菌富集。

研究设计与样本

  • 伞状更新荟萃分析,检索 Cochrane Library、PubMed、PsycINFO 和 Embase 至2021年2月2日,纳入59项病例对照研究。
  • α多样性荟萃分析纳入34项研究,共1519例患者和1429例对照。

主要发现

  • 患者微生物丰富度显著低于对照:观察物种 SMD=-0.26(95%CI -0.47至-0.06),Chao1 SMD=-0.5(95%CI -0.79至-0.21)。
  • 系统发育多样性小幅降低:SMD=-0.24(95%CI -0.47至-0.001),Shannon和Simpson指数无显著差异。
  • β多样性差异仅一致见于重性抑郁障碍和精神分裂症。
  • 相对丰度缺乏疾病特异性,Faecalibacterium和Coprococcus耗竭、Eggerthella富集在重性抑郁障碍、双相障碍、精神分裂症和焦虑中共享。

临床怎么用

  • 提示精神科临床可关注跨诊断的肠道菌群失调模式,但尚不能作为特异性生物标志物使用。

局限性

  • 地区与药物等混杂关联已被评估,但原文未报告具体控制方法或残余混杂程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Evidence of gut microbiota perturbations has accumulated for multiple psychiatric disorders, with microbiota signatures proposed as potential biomarkers. However, no attempts have been made to evaluate the specificity of these across the range of psychiatric conditions. OBJECTIVE: To conduct an umbrella and updated meta-analysis of gut microbiota alterations in general adult psychiatric populations and perform a within- and between-diagnostic comparison. DATA SOURCES: Cochrane Library, PubMed, PsycINFO, and Embase were searched up to February 2, 2021, for systematic reviews, meta-analyses, and original evidence. STUDY SELECTION: A total of 59 case-control studies evaluating diversity or abundance of gut microbes in adult populations with major depressive disorder, bipolar disorder, psychosis and schizophrenia, anorexia nervosa, anxiety, obsessive compulsive disorder, posttraumatic stress disorder, or attention-deficit/hyperactivity disorder were included. DATA EXTRACTION AND SYNTHESIS: Between-group comparisons of relative abundance of gut microbes and beta diversity indices were extracted and summarized qualitatively. Random-effects meta-analyses on standardized mean difference (SMD) were performed for alpha diversity indices. MAIN OUTCOMES AND MEASURES: Alpha and beta diversity and relative abundance of gut microbes. RESULTS: A total of 34 studies provided data and were included in alpha diversity meta-analyses (n = 1519 patients, n = 1429 control participants). Significant decrease in microbial richness in patients compared with control participants were found (observed species SMD = -0.26; 95% CI, -0.47 to -0.06; Chao1 SMD = -0.5; 95% CI, -0.79 to -0.21); however, this was consistently decreased only in bipolar disorder when individual diagnoses were examined. There was a small decrease in phylogenetic diversity (SMD = -0.24; 95% CI, -0.47 to -0.001) and no significant differences in Shannon and Simpson indices. Differences in beta diversity were consistently observed only for major depressive disorder and psychosis and schizophrenia. Regarding relative abundance, little evidence of disorder specificity was found. Instead, a transdiagnostic pattern of microbiota signatures was found. Depleted levels of Faecalibacterium and Coprococcus and enriched levels of Eggerthella were consistently shared between major depressive disorder, bipolar disorder, psychosis and schizophrenia, and anxiety, suggesting these disorders are characterized by a reduction of anti-inflammatory butyrate-producing bacteria, while pro-inflammatory genera are enriched. The confounding associations of region and medication were also evaluated. CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that gut microbiota perturbations were associated with a transdiagnostic pattern with a depletion of certain anti-inflammatory butyrate-producing bacteria and an enrichment of pro-inflammatory bacteria in patients with depression, bipolar disorder, schizophrenia, and anxiety.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Nikolova VL, Smith MRB, Hall LJ, et al. Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis. JAMA Psychiatry. 2021. PMID: 34524405. doi:10.1001/jamapsychiatry.2021.2573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。